CALL TODAY FOR NEW CUSTOMER DISCOUNTS - 1.877.421.7160

ellura® has received herbal medicine approvals worldwide:

The following countries have approved ellura as an herbal medicine under the following indication: used in the prevention of recurrent acute uncomplicated urinary tract infections (cystitis).

France

Traditional Herbal Medicine - 2020

Holland

Traditional Herbal Medicine - 2019

Brazil

Traditional Herbal Medicine - 2017

Canada

Natural Health Product - 2017

Mexico

Herbal Medicine - 2017

Spain

Traditional Herbal Medicine - 2017

United Kingdom

Traditional Herbal Medicine - 2016

South Africa

Western Herbal Medicine - 2015

Australia

Listed Medicine - 2014

Malaysia

Traditional Herbal Medicine - 2012


Belgium and Portugal are expected approvals in 2020 with 15 additional countries in early application process.

Getting to where we are today:

2004: French company Pharmatoka petitions AFSSA (the French food safety agency) to confirm that PAC (proanthocyanidins) can inhibit bacteria from sticking to the urinary tract – known as the anti-adhesion effect.
 
AFSSA issues a health claim based on studies using supplements with 36 mg PAC.

2010: French DGCCRF (Directorate General for Competition, Consumer Affairs and Fraud Control) requires commercial products listing the claim to use the DMAC method [4-(dimethylamino)cinnamaldehyde] to measure PAC.

2011: The French food safety agency (now called ANSES) reviews additional studies and reaffirms that cranberry supplements with 36 mg PAC perform as claimed. Click here to learn more about the DMAC/A2 method now considered the gold standard in measuring PAC content.

Global launch

After the 2004 confirmation, Pharmatoka launches urell®, the only cranberry product to contain 36 mg PAC measured by DMAC/A2. Urell gains in popularity and is rolled out worldwide, entering the U.S. market as ellura in late 2010. Today, a rapidly growing base of physicians and patients all over the globe trust ellura to maintain a clean urinary tract.